Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
DNA Walker-Regulated Cancer Cell Growth Inhibition
Date
2016-06-01
Author
Li, Feiran
Cha, Tae-Gon
Pan, Jing
Özçelikkale, Altuğ
Han, Bumsoo
Choi, Jong Hyun
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
115
views
0
downloads
Cite This
We demonstrate a DNAzyme-based walker system as a controlled oligonucleotide drug AS1411 release platform for breast cancer treatment. In this system, AS1411 strands are released from fuel strands as a walker moves along its carbon nanotube track. The release rate and amount of anticancer oligonucleotides are controlled by the walker operation. With a walker system embedded within the collagen extracellular matrix, we show that this drug release system can be used for in situ cancer cell growth inhibition.
Subject Keywords
Organic Chemistry
,
Molecular Medicine
,
Biochemistry
,
Molecular Biology
URI
https://hdl.handle.net/11511/69453
Journal
CHEMBIOCHEM
DOI
https://doi.org/10.1002/cbic.201600052
Collections
Department of Mechanical Engineering, Article
Suggestions
OpenMETU
Core
Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer
BAYRAÇ, TAHİR; Akca, Oya Ercan; Eyidogan, Fusun Inci; Öktem, Hüseyin Avni (Springer Science and Business Media LLC, 2018-03-01)
Targeted drug delivery approaches have been implementing significant therapeutic gain for cancer treatment since last decades. Aptamers are one of the mostly used and highly selective targeting agents for cancer cells. Herein, we address a nano-sized targeted drug delivery approach adorned with A-172 glioblastoma cell-line-specific single stranded DNA (ssDNA) aptamer in which the chemotherapeutic agent Doxorubicin (DOX) had been conjugated. DNA aptamer, GMT-3, was previously selected for specific recognitio...
Amifostine, a radioprotectant agent, protects rat brain tissue lipids against ionizing radiation induced damage: An FTIR microspectroscopic imaging study
Cakmak, Gulgun; Miller, Lisa M.; Zorlu, Faruk; Severcan, Feride (Elsevier BV, 2012-04-15)
Amifostine is the only approved radioprotective agent by FDA for reducing the damaging effects of radiation on healthy tissues. In this study, the protective effect of amifostine against the damaging effects of ionizing radiation on the white matter (WM) and grey matter (GM) regions of the rat brain were investigated at molecular level. Sprague-Dawley rats, which were administered amifostine or not, were whole-body irradiated at a single dose of 800 cGy, decapitated after 24 h and the brain tissues of these...
Modulation of human flavin-containing monooxygenase 3 activity by tricyclic antidepressants and other agents: Importance of residue 428
Adalı, Orhan; Philpot, RM (Elsevier BV, 1998-10-01)
Human flavin-containing monooxygenase 3 (FMO3) is subject to modulation by tricyclic antidepressants and other agents. Imipramine activates FMO3-catalyzed metabolism of methimazole at all substrate concentrations tested. This distinguishes FMO3 from rabbit FMO1 and FMO2, which are activated at high substrate concentration and inhibited at low substrate concentration, and pig FMO1, which is inhibited at all substrate concentrations. The response of FMO3 is also unique in that chlorpromazine is markedly more ...
Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles
Ozek, Nihal Simsek; Bal, I. Burak; SARA, MEHMET YILDIRIM; Onur, Rustu; Severcan, Feride (Elsevier BV, 2014-01-01)
Background: Statins are the most commonly used drugs for the treatment of hypercholesterolemia. Their most frequent side effect is myotoxicity. To date, it remains unclear whether statins preferentially induce myotoxicity in fast- or in slow-twitch muscles. Therefore, we investigated these effects on fast- (extensor digitorum longus; EDL), slow- (soleus; SOL), and mixed-twitch muscles (diaphragm; DIA) in rats by comparing their contractile and molecular structural properties.
Regulation of biofilm formation bymarTinSalmonellaTyphimurium
Eran, Zeynep; AKÇELİK, MUSTAFA; Yazici, Betul Cansu; Özcengiz, Gülay; AKÇELİK, NEFİSE (Springer Science and Business Media LLC, 2020-07-01)
In this study, we aimed at identifying the regulatory role ofmarTgene, known as the regulator ofmisL, on 15 different biofilm-related genes inS.Typhimurium 14028 strain. We also tested the strains for their ability to form biofilm and determined the adherence characteristics of the wild type and the mutant strains of the organism on Caco-2 and HEp-2 cells. For comparative analyses of the candidate genes, individual gene mutations were created via antibiotic gene cassette insertion into each gene of interest...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
F. Li, T.-G. Cha, J. Pan, A. Özçelikkale, B. Han, and J. H. Choi, “DNA Walker-Regulated Cancer Cell Growth Inhibition,”
CHEMBIOCHEM
, pp. 1138–1141, 2016, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/69453.